Free Trial

Modular Medical (MODD) Competitors

Modular Medical logo
$4.86 +0.22 (+4.74%)
Closing price 06/8/2026 03:55 PM Eastern
Extended Trading
$4.94 +0.08 (+1.73%)
As of 06/8/2026 06:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

MODD vs. HSDT, NRXS, OM, AGPU, and IINN

Should you buy Modular Medical stock or one of its competitors? MarketBeat compares Modular Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Modular Medical include Solana (HSDT), NeurAxis (NRXS), Outset Medical (OM), Predictive Oncology (AGPU), and Inspira Technologies OXY B.H.N. (IINN). These companies are all part of the "medical equipment" industry.

How does Modular Medical compare to Solana?

Solana (NASDAQ:HSDT) and Modular Medical (NASDAQ:MODD) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, earnings, risk, dividends, analyst recommendations, profitability and media sentiment.

Modular Medical has lower revenue, but higher earnings than Solana. Modular Medical is trading at a lower price-to-earnings ratio than Solana, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Solana$6.02M13.39-$40.89M-$109.67N/A
Modular MedicalN/AN/A-$18.82M-$14.71N/A

18.6% of Solana shares are owned by institutional investors. Comparatively, 27.5% of Modular Medical shares are owned by institutional investors. 14.4% of Solana shares are owned by insiders. Comparatively, 7.1% of Modular Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Solana's average media sentiment score of 0.00 equaled Modular Medical'saverage media sentiment score.

Company Overall Sentiment
Solana Neutral
Modular Medical Neutral

Solana has a beta of 1.06, suggesting that its share price is 6% more volatile than the broader market. Comparatively, Modular Medical has a beta of 0.31, suggesting that its share price is 69% less volatile than the broader market.

Modular Medical has a net margin of 0.00% compared to Solana's net margin of -1,427.15%. Solana's return on equity of -67.57% beat Modular Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Solana-1,427.15% -67.57% -24.09%
Modular Medical N/A -245.85%-190.80%

Solana presently has a consensus target price of $3.50, suggesting a potential upside of 153.62%. Given Solana's stronger consensus rating and higher possible upside, research analysts plainly believe Solana is more favorable than Modular Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Solana
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50
Modular Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Solana beats Modular Medical on 10 of the 14 factors compared between the two stocks.

How does Modular Medical compare to NeurAxis?

Modular Medical (NASDAQ:MODD) and NeurAxis (NASDAQ:NRXS) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, risk, valuation, institutional ownership, analyst recommendations and earnings.

NeurAxis has a consensus price target of $13.00, indicating a potential upside of 94.90%. Given NeurAxis' stronger consensus rating and higher probable upside, analysts plainly believe NeurAxis is more favorable than Modular Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Modular Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
NeurAxis
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

NeurAxis has higher revenue and earnings than Modular Medical. NeurAxis is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Modular MedicalN/AN/A-$18.82M-$14.71N/A
NeurAxis$4.28M19.29-$14.63M-$0.81N/A

Modular Medical has a beta of 0.31, indicating that its share price is 69% less volatile than the broader market. Comparatively, NeurAxis has a beta of 1.42, indicating that its share price is 42% more volatile than the broader market.

In the previous week, NeurAxis had 1 more articles in the media than Modular Medical. MarketBeat recorded 1 mentions for NeurAxis and 0 mentions for Modular Medical. Modular Medical's average media sentiment score of 0.00 equaled NeurAxis'average media sentiment score.

Company Overall Sentiment
Modular Medical Neutral
NeurAxis Neutral

27.5% of Modular Medical shares are held by institutional investors. Comparatively, 11.8% of NeurAxis shares are held by institutional investors. 7.1% of Modular Medical shares are held by insiders. Comparatively, 21.1% of NeurAxis shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Modular Medical has a net margin of 0.00% compared to NeurAxis' net margin of -492.76%. NeurAxis' return on equity of 0.00% beat Modular Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Modular MedicalN/A -245.85% -190.80%
NeurAxis -492.76%N/A -641.25%

Summary

NeurAxis beats Modular Medical on 10 of the 14 factors compared between the two stocks.

How does Modular Medical compare to Outset Medical?

Modular Medical (NASDAQ:MODD) and Outset Medical (NASDAQ:OM) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, risk, valuation and profitability.

Outset Medical has a consensus target price of $10.00, suggesting a potential upside of 131.48%. Given Outset Medical's stronger consensus rating and higher probable upside, analysts plainly believe Outset Medical is more favorable than Modular Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Modular Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Outset Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

Modular Medical has higher earnings, but lower revenue than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Modular MedicalN/AN/A-$18.82M-$14.71N/A
Outset Medical$119.48M0.67-$81.65M-$4.16N/A

In the previous week, Outset Medical had 4 more articles in the media than Modular Medical. MarketBeat recorded 4 mentions for Outset Medical and 0 mentions for Modular Medical. Modular Medical's average media sentiment score of 0.00 beat Outset Medical's score of -0.05 indicating that Modular Medical is being referred to more favorably in the media.

Company Overall Sentiment
Modular Medical Neutral
Outset Medical Neutral

27.5% of Modular Medical shares are owned by institutional investors. 7.1% of Modular Medical shares are owned by company insiders. Comparatively, 2.5% of Outset Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Modular Medical has a beta of 0.31, suggesting that its share price is 69% less volatile than the broader market. Comparatively, Outset Medical has a beta of 1.95, suggesting that its share price is 95% more volatile than the broader market.

Modular Medical has a net margin of 0.00% compared to Outset Medical's net margin of -63.65%. Outset Medical's return on equity of -56.13% beat Modular Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Modular MedicalN/A -245.85% -190.80%
Outset Medical -63.65%-56.13%-27.45%

Summary

Outset Medical beats Modular Medical on 9 of the 15 factors compared between the two stocks.

How does Modular Medical compare to Predictive Oncology?

Predictive Oncology (NASDAQ:AGPU) and Modular Medical (NASDAQ:MODD) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, earnings, analyst recommendations, valuation, media sentiment and institutional ownership.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Predictive Oncology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Modular Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Modular Medical has a net margin of 0.00% compared to Predictive Oncology's net margin of -470,383.31%. Modular Medical's return on equity of -245.85% beat Predictive Oncology's return on equity.

Company Net Margins Return on Equity Return on Assets
Predictive Oncology-470,383.31% -7,363.67% -626.32%
Modular Medical N/A -245.85%-190.80%

9.0% of Predictive Oncology shares are held by institutional investors. Comparatively, 27.5% of Modular Medical shares are held by institutional investors. 1.2% of Predictive Oncology shares are held by insiders. Comparatively, 7.1% of Modular Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Predictive Oncology has a beta of 3.47, meaning that its stock price is 247% more volatile than the broader market. Comparatively, Modular Medical has a beta of 0.31, meaning that its stock price is 69% less volatile than the broader market.

Modular Medical has lower revenue, but higher earnings than Predictive Oncology. Predictive Oncology is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Predictive Oncology$120K634.40-$233.10M-$8.18N/A
Modular MedicalN/AN/A-$18.82M-$14.71N/A

In the previous week, Modular Medical's average media sentiment score of 0.00 beat Predictive Oncology's score of -0.35 indicating that Modular Medical is being referred to more favorably in the news media.

Company Overall Sentiment
Predictive Oncology Neutral
Modular Medical Neutral

Summary

Modular Medical beats Predictive Oncology on 8 of the 11 factors compared between the two stocks.

How does Modular Medical compare to Inspira Technologies OXY B.H.N.?

Inspira Technologies OXY B.H.N. (NASDAQ:IINN) and Modular Medical (NASDAQ:MODD) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability, media sentiment and analyst recommendations.

12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. Comparatively, 27.5% of Modular Medical shares are owned by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Comparatively, 7.1% of Modular Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Inspira Technologies OXY B.H.N. has higher revenue and earnings than Modular Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspira Technologies OXY B.H.N.$289K176.64-$13.22MN/AN/A
Modular MedicalN/AN/A-$18.82M-$14.71N/A

In the previous week, Inspira Technologies OXY B.H.N. had 1 more articles in the media than Modular Medical. MarketBeat recorded 1 mentions for Inspira Technologies OXY B.H.N. and 0 mentions for Modular Medical. Inspira Technologies OXY B.H.N.'s average media sentiment score of 0.00 equaled Modular Medical'saverage media sentiment score.

Company Overall Sentiment
Inspira Technologies OXY B.H.N. Neutral
Modular Medical Neutral

Inspira Technologies OXY B.H.N. has a beta of 2.16, suggesting that its stock price is 116% more volatile than the broader market. Comparatively, Modular Medical has a beta of 0.31, suggesting that its stock price is 69% less volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Modular Medical
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Modular Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Inspira Technologies OXY B.H.N.N/A N/A N/A
Modular Medical N/A -245.85%-190.80%

Summary

Inspira Technologies OXY B.H.N. beats Modular Medical on 7 of the 8 factors compared between the two stocks.

Get Modular Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for MODD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MODD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MODD vs. The Competition

MetricModular MedicalMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$21.63M$8.39B$6.47B$11.98B
Dividend YieldN/A2.52%2.67%5.58%
P/E Ratio-0.3316.1623.6923.74
Price / SalesN/A5.72533.79119.57
Price / CashN/A17.4526.9937.25
Price / Book0.393.5510.366.78
Net Income-$18.82M$225.32M$3.57B$337.51M
7 Day Performance1.46%0.58%0.27%-2.34%
1 Month Performance28.57%2.21%3.26%1.88%
1 Year Performance-80.10%-3.45%22.22%25.55%

Modular Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MODD
Modular Medical
0.2293 of 5 stars
$4.86
+4.7%
N/A-80.8%$21.63MN/AN/A20
HSDT
Solana
2.6942 of 5 stars
$1.48
-7.8%
$3.50
+137.3%
-97.5%$86.13M$6.02MN/A30
NRXS
NeurAxis
2.6767 of 5 stars
$6.94
-1.0%
$13.00
+87.3%
+155.6%$85.91M$4.28MN/A19
OM
Outset Medical
2.5548 of 5 stars
$4.54
-10.5%
$10.00
+120.3%
-79.4%$84.17M$119.48MN/A520
AGPU
Predictive Oncology
0.3687 of 5 stars
$8.09
-7.7%
N/AN/A$84.08M$120KN/A30

Related Companies and Tools


This page (NASDAQ:MODD) was last updated on 6/9/2026 by MarketBeat.com Staff.
From Our Partners